Stephanie Land , PhD
Research Area: Tobacco use among cancer patients, tobacco use and cancer chemoprevention, tobacco regulatory science
Stephanie Land is a Program Director in the Behavioral Research Program's (BRP) Tobacco Control Research Branch (TCRB), housed within the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI). Her areas of focus are tobacco use among cancer patients and tobacco regulatory science (relevant to the Family Smoking Prevention and Tobacco Control Act). She is the chair of the DCCPS Clinical Trials Coordination Group, an Associate Editor for the Journal of Clinical Oncology, a member of the NCI Special Studies Institutional Review Board, a member of the American Association for Cancer Research (AACR) Tobacco and Cancer Subcommittee, and the chair of the NCI-AACR Cancer Patient Tobacco Use Assessment Task Force. Prior to joining the NCI, Dr. Land was the co-founder and director of the Reduce Smoking and Exposure to Tobacco (ReSET) Center and an Associate Professor of Biostatistics at the University of Pittsburgh, and a member of the American Schools of Public Health Tobacco Use Council. She was the PI for an NCI-funded project regarding smoking and other lifestyle behaviors as predictors of patient adherence to chemoprevention in the setting of breast cancer, and PI for an intramurally-funded study of tobacco use and social network formation during the first year of college.
Dr. Land currently has over 90 research publications in print. Since 1999, she has been a statistician in the National Surgical Adjuvant Breast and Bowel Project (NSABP), an NCI-funded clinical trials cooperative group that conducts multi-center phase III trials for breast and colorectal cancer. Her primary role in the NSABP was as the lead statistician for the Behavioral and Health Outcomes Program. She has also collaborated with members of the University of Pittsburgh Cancer Institute Lung and Thoracic Malignancies Program since 1999, and served as the lead statistician for the Lung Cancer Specialized Program of Research Excellence (SPORE) since 2002, directing the Core through two competing renewals. Her prior service to the NCI includes participation in the Community Clinical Oncology Program (CCOP) Research Priorities Strategic Planning Committee (NCI), Subcommittee H (reviewing cooperative groups), the NCI Symptom Management and Quality of Life Scientific Steering Committee, and numerous NCI grant review panels. Dr. Land earned a Doctorate in Statistics from Stanford University in 1995.
Secondary Branch Appointment:
Science of Research and Technology Branch (SRTB)
Current and past BRP mentors include Sarah Kobrin.